This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Elefanty, A G Articles by Cory, S Search for Related Content PubMed PubMed Citation Articles by Elefanty, A G Articles by Cory, S

 Previous Article  |  Next Article 

Mol Cell Biol. 1992 April; 12(4): 1755-1763

Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions.

Walter and Eliza Hall Institute of Medical Research, Post Office Royal Melbourne Hospital, Victoria, Australia.

ABSTRACT

Irradiated mice reconstituted with bone marrow cells infected with a retrovirus carrying the bcr-abl oncogene of human chronic myeloid leukemia are subject to a range of neoplastic hematopoietic diseases, both myeloid and lymphoid. Comparison of DBA/2 and C57BL/6 mice has revealed a marked strain difference in susceptibility to the various tumor types. The present study, performed with BALB/c mice, indicates that the kinetics and nature of the induced disease can be modulated by the infection procedure, as well as the genetic background, and that retroviral regulatory sequences may influence the outcome. A distinctive clonal myeloproliferative disorder, somewhat akin to chronic myeloid leukemia but with prominent erythroid and mast cell components, as well as granulocytic excess, was characterized.

This article has been cited by other articles:

• Wiesner, S. M., Jones, J. M., Hasz, D. E., Largaespada, D. A. (2005). Repressible transgenic model of NRAS oncogene-driven mast cell disease in the mouse. Blood 106: 1054-1062 [Abstract] [Full Text]  
• Wolff, N. C., Ilaria, R. L. Jr (2001). Establishment of a murine model for therapy-treated chronic myelogenous leukemia using the tyrosine kinase inhibitor STI571. Blood 98: 2808-2816 [Abstract] [Full Text]  
• Zhang, X., Subrahmanyam, R., Wong, R., Gross, A. W., Ren, R. (2001). The NH2-Terminal Coiled-Coil Domain and Tyrosine 177 Play Important Roles in Induction of a Myeloproliferative Disease in Mice by Bcr-Abl. Mol. Cell. Biol. 21: 840-853 [Abstract] [Full Text]  
• Zhang, X., Wong, R., Hao, S. X., Pear, W. S., Ren, R. (2001). The SH2 domain of Bcr-Abl is not required to induce a murine myeloproliferative disease; however, SH2 signaling influences disease latency and phenotype. Blood 97: 277-287 [Abstract] [Full Text]  
• Deininger, M. W. N., Goldman, J. M., Melo, J. V. (2000). The molecular biology of chronic myeloid leukemia. Blood 96: 3343-3356 [Full Text]  
• Sexl, V., Piekorz, R., Moriggl, R., Rohrer, J., Brown, M. P., Bunting, K. D., Rothammer, K., Roussel, M. F., Ihle, J. N. (2000). Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of Stat5. Blood 96: 2277-2283 [Abstract] [Full Text]  
• Honda, H., Ushijima, T., Wakazono, K., Oda, H., Tanaka, Y., Aizawa, S.-i., Ishikawa, T., Yazaki, Y., Hirai, H. (2000). Acquired loss of p53 induces blastic transformation in p210bcr/abl-expressing hematopoietic cells: a transgenic study for blast crisis of human CML. Blood 95: 1144-1150 [Abstract] [Full Text]  
• Gross, A. W., Zhang, X., Ren, R. (1999). Bcr-Abl with an SH3 Deletion Retains the Ability To Induce a Myeloproliferative Disease in Mice, yet c-Abl Activated by an SH3 Deletion Induces Only Lymphoid Malignancy. Mol. Cell. Biol. 19: 6918-6928 [Abstract] [Full Text]  
• Li, S., Ilaria, R. L. Jr., Million, R. P., Daley, G. Q., Van Etten, R. A. (1999). The P190, P210, and P230 Forms of the BCR/ABL Oncogene Induce a Similar Chronic Myeloid Leukemia-like Syndrome in Mice but Have Different Lymphoid Leukemogenic Activity. J. Exp. Med. 189: 1399-1412 [Abstract] [Full Text]  
• MacKenzie, K.L., Dolnikov, A., Millington, M., Shounan, Y., Symonds, G. (1999). Mutant N-ras Induces Myeloproliferative Disorders and Apoptosis in Bone Marrow Repopulated Mice. Blood 93: 2043-2056 [Abstract] [Full Text]  
• Pear, W. S., Miller, J. P., Xu, L., Pui, J. C., Soffer, B., Quackenbush, R. C., Pendergast, A. M., Bronson, R., Aster, J. C., Scott, M. L., Baltimore, D. (1998). Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow. Blood 92: 3780-3792 [Abstract] [Full Text]  
• Honda, H., Oda, H., Suzuki, T., Takahashi, T., Witte, O. N., Ozawa, K., Ishikawa, T., Yazaki, Y., Hirai, H. (1998). Development of Acute Lymphoblastic Leukemia and Myeloproliferative Disorder in Transgenic Mice Expressing p210bcr/abl: A Novel Transgenic Model for Human Ph1-Positive Leukemias. Blood 91: 2067-2075 [Abstract] [Full Text]  
• Kuefer, M. U., Look, A. T., Pulford, K., Behm, F. G., Pattengale, P. K., Mason, D. Y., Morris, S. W. (1997). Retrovirus-Mediated Gene Transfer of NPM-ALK Causes Lymphoid Malignancy in Mice. Blood 90: 2901-2910 [Abstract] [Full Text]